These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38550056)

  • 1. Retracted: Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9862563. PubMed ID: 38550056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
    Wang X; Shi D; Zhao D; Hu D
    Biomed Res Int; 2020; 2020():1807089. PubMed ID: 33029490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathogenesis of Gene Regulation by the
    Misono S; Seki N; Mizuno K; Yamada Y; Uchida A; Sanada H; Moriya S; Kikkawa N; Kumamoto T; Suetsugu T; Inoue H
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31052206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining TCGA and GEO databases for the prediction of poor prognosis in lung adenocarcinoma based on up-regulated expression of TNS4.
    Liu F; Gao X; Liu W; Xue W
    Medicine (Baltimore); 2022 Oct; 101(42):e31120. PubMed ID: 36281194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
    Asian Pac J Cancer Prev; 2017 Nov; 18(10):2895-2895. PubMed ID: 29171745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Li R; Gao Y; Qiu B; Tan F; Xue Q; Gao S; He J
    DNA Cell Biol; 2020 Apr; 39(4):631-644. PubMed ID: 32096653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming induced by inhibition of SLC2A1 suppresses tumor progression in lung adenocarcinoma.
    Wang Y; Shi S; Ding Y; Wang Z; Liu S; Yang J; Xu T
    Int J Clin Exp Pathol; 2017; 10(11):10759-10769. PubMed ID: 31966419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Expression of CX3CL1 and CCL28 in Spinal Metastases of Lung Adenocarcinoma and Their Correlation with Clinical Features and Prognosis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9812681. PubMed ID: 37476737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database.
    Oncology JO
    J Oncol; 2023; 2023():9815674. PubMed ID: 37476556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.
    He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q
    Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Activation of Tensin 4 Promotes Gastric Cancer Progression.
    Heo H; Kim HJ; Haam K; Sohn HA; Shin YJ; Go H; Jung HJ; Kim JH; Lee SI; Song KS; Kim MJ; Lee H; Kwon ES; Kim SY; Kim YS; Kim M
    Mol Cells; 2023 May; 46(5):298-308. PubMed ID: 36896596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of Tensin4 expression in human gastric cancer.
    Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
    Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wang Y; Wen H; Sun D
    Ann Transl Med; 2022 May; 10(9):519. PubMed ID: 35928739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CASZ1 promotes migration, invasion, and metastasis of lung cancer cells by controlling expression of ITGAV.
    Taheri Baghmisheh S; Wu YY; Wu JE; Hsu KF; Chen YL; Hong TM
    Am J Cancer Res; 2023; 13(1):176-189. PubMed ID: 36777515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma.
    Tanaka R; Wang D; Morishita Y; Inadome Y; Minami Y; Iijima T; Fukai S; Goya T; Noguchi M
    Cancer; 2005 Feb; 103(3):608-15. PubMed ID: 15612080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells.
    International BR
    Biomed Res Int; 2024; 2024():9867431. PubMed ID: 38550164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis identifies the association between
    Mo XB; Zhang H; Wang AL; Xu T; Zhang YH
    Neurol Genet; 2020 Oct; 6(5):e509. PubMed ID: 33134510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9793270. PubMed ID: 37501866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma.
    International BR
    Biomed Res Int; 2023; 2023():9846745. PubMed ID: 37388346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma.
    Markers D
    Dis Markers; 2023; 2023():9896249. PubMed ID: 37829124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.